Lymphedema, Breast Cancer
Conditions
Keywords
Lymphedema, ESWT, LLLT
Brief summary
This study aimed to comparatively investigate the effects of ESWT and LLLT added to conventional CDT (which is the standard treatment for breast cancer-related lymphedema) on patients' limb volume, pain intensity, functional status and quality of life.
Detailed description
after being informed study and potential risks, all patient giving written informed consent will undergo screening period determine eligibility for study entry. The patients who meet the eligibility recruitments will get treatment into three groups in conventional complet decongestive therapy (CDT) program, electrocorporeal shock wave therapy (ESWT) combined with CDT program and low level laser therapy (LLLT) combined with CDT program
Interventions
DEVICEESWT
ESWT was applied to the second group for a total of 5 sessions, 2 sessions in the first two weeks and 1 session in the last week. .
DEVICELLLT
In the third group, LLLT was applied for a total of 9 sessions, 3 sessions per week, in addition to conventional CDT.
conventional CDT program consisting of MLD, compression bandage, skin care and lymphedema exercises, for a total of 15 sessions, five days a week for three weeks.
Sponsors
Ankara City Hospital Bilkent
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
FEMALE
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* Female patients with unilateral lymphedema after breast cancer-related surgery Patients whose chemotherapy and radiotherapy protocols have been completed Patients with stage 2 lymphedema according to ISL staging
Exclusion criteria
* Patients with arm edema before breast cancer * Patients with ongoing chemotherapy and radiotherapy Those with metastatic breast cancer Patients with acute infection Patients with BMI \>35 Patients with pregnancy Patients who have previously received KDT Patients with active cancer Patients with recurrence or metastasis of breast cancer on follow-up imaging Those with decompensated heart failure Those with kidney failure Patients with liver failure Patients with a history of deep vein thrombosis in the last 3 months Those who are allergic to the dressing materials to be applied Patients with active infection or open wound on their extremities Those with cognitive impairment Patients with sensory deficits Immobilized patients
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Extremity volumes | Baseline, after three weeks | Upper limb Volume measured by perometer |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Lymphedema Quality of Life-arm (LYMQOL-arm ) | Baseline, after three weeks | quality of life questionnaire that is spesific for upper limb lymphedema |
| Disabilities of the Arm, Shoulder and Hand (DASH) Questionnaire | Baseline, after three weeks | questionnaire that shows functional status |
| Visual Anologue Scale -Pain (VAS) | Baseline, after three weeks | a straight line with one end meaning no pain and the other end meaning the worst pain imaginable |
Countries
Turkey (Türkiye)
Outcome results
None listed